Atropos Health AI $33M Series By Valtruislandi

California-based, Atropos Health, an AI-enabled health-tech platform that translates clinical data in real-world word care programs, raised $33 million led by Valtruis in a Series B round.

The round was actively participated by McKesson Ventures, Cencora Ventures, and Merck GHI Fund. Some existing investors including Emerson Collective, Breyer Capital, and Presidio Ventures backed the round.

Atropos Health Announces $33M Series B

Brigham Hyde said that the funds raised in the round will enable us for the development of the platform, and R&D.

Brigham Hyde, Nigam Shah, and Saurabh Gombar founded Atropos Health AI technology at Stanford University in 2019. Atropos Health developed GENEVA OSTM. It is an advanced operating system that translates healthcare and clinical evidence into real-world data.

Moreover, Atropos Health works with healthcare organizations to fill the gap with a data-driven approach so that it helps in making clinical decisions that drive high value at low cost.

Also Read: Los Angeles-Based Machina Labs AI $32M Series

Also Read: How to Build a Successful Online Poker Bankroll?

By Admin

Leave a Reply

Your email address will not be published. Required fields are marked *